Population
Patients with or at risk for Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Design
Review
Authors
Loading...
Underscores need for early ARVC risk stratification; leaves open optimal timing of interventions in mutation carriers.
ARVC is a progressive cardiomyopathy requiring early diagnosis, risk stratification, and management strategies including exercise restriction, ICD implantation, and genetic screening.
Yongkeun Cho (2018) studied this question.